Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

JAGX Oct 2021 2.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.04000.0000 (0.00%)
At close: 12:41PM EDT
Advertisement
Full screen
Previous Close0.0400
Open0.0400
Bid0.0000
Ask0.0500
Strike2.50
Expire Date2021-10-15
Day's Range0.0400 - 0.0400
Contract RangeN/A
Volume1
Open Interest653
  • ACCESSWIRE

    Jaguar Health Provides Updates on Crofelemer and Lechlemer Development Pipeline as well as Merger of Napo EU S.p.A. and Dragon SPAC S.p.A.

    Dragon SPAC and Jaguar subsidiary Napo EU submit required notification to the Italian government in support of consummating the mergerResults accepted for third-party, investigator-initiated Phase 2 HALT-D study evaluating crofelemer for prevention and prophylaxis of diarrhea in breast cancer patients as a poster for December 2021 San Antonio Breast Cancer SymposiumSAN FRANCISCO, CA / ACCESSWIRE / October 7, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) provided updates today regarding ongoing resear

  • ACCESSWIRE

    Jaguar Health's Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award

    Conte's 30-year, unrelenting commitment to supporting Indigenous communities in the Amazon and responsibly harvesting and commercializing the first-ever plant-based oral medicine approved under FDA Botanical GuidanceSAN FRANCISCO, CA / ACCESSWIRE / September 30, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Pure Earth, an international non-profit organization that is a leader in the global fight to reduce disease-causing pollution, is awarding Jaguar's Founder, President, and Chi

  • ACCESSWIRE

    Jaguar Health Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Cancer Therapy-related Diarrhea on September 29, 2021

    Leading oncologists discuss importance of supportive care for cancer patients to address debilitating diarrhea resulting from cancer therapy Virtual event 1:00 PM to 2:10 PM Eastern Registration open now for financial and business community; Click here to registerSAN FRANCISCO, CA / ACCESSWIRE / September 27, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Ladenburg Thalmann is hosting an R&D Showcase webinar about cancer therapy-related diarrhea (CTD) on September 29, 2021 from 1:

Advertisement
Advertisement